{"title":"Effect of Dietary Intervention in Paediatric Patients with Chronic Spontaneous Urticaria: Open Labelled Randomised Controlled Trial.","authors":"Aritra Kapat, Raghunath Murmu, Satyajit Mandal, Koushik Biswas, Nilendu Sarma, Ashok Kumar Bala","doi":"10.26574/maedica.2025.20.2.275","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Chronic spontaneous urticaria (CSU) is a skin disorder characterized by itchy wheal, angioedema or both that persists for over six weeks. 'Pseudoallergens' in food induce hypersensitive reactions similar to true allergic reactions and are linked to CSU. These consist of food additives, vasoactive amines (histamine) and a few natural substances in fruits, vegetables and spices. This study aimed to investigate if dietary restriction (pseudoallergen-free and low histamine diet) can improve the clinical outcome in paediatric CSU patients.</p><p><strong>Materials and methods: </strong>The present open-label randomized control trial was conducted in a paediatric tertiary care centre of Eastern India from September 2021 to August 2022. Paediatric CSU patients (n=140) attending the centre were randomly allocated to one of two treatment interventions: DR group (n=70, drug) or DRDI group (n=70, drugs and dietary intervention). Both groups were compared at baseline. The weekly urticaria activity score (UAS7) was calculated by trained parents. All data were entered in an Excel spreadsheet. T-test was used to compare the UAS7 of both groups at baseline, three and six weeks of treatment.</p><p><strong>Results: </strong>There was no significant difference in demographic characteristics, clinical features, laboratory parameters and weekly urticaria activity score (UAS7) between groups at baseline. After six weeks of treatment, the UAS7 of patients in the DRDI group was lower as compared to those in the DR group (8.80±4.27 vs 10.19±4.66), though statistically insignificant (t=1.79, p=0.07).</p><p><strong>Conclusion: </strong>Pseudoallergen-free diet is a safe and cost-effective measure to decrease CSU patients' symptoms.</p>","PeriodicalId":74094,"journal":{"name":"Maedica","volume":"20 2","pages":"275-282"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12347017/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Maedica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26574/maedica.2025.20.2.275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Chronic spontaneous urticaria (CSU) is a skin disorder characterized by itchy wheal, angioedema or both that persists for over six weeks. 'Pseudoallergens' in food induce hypersensitive reactions similar to true allergic reactions and are linked to CSU. These consist of food additives, vasoactive amines (histamine) and a few natural substances in fruits, vegetables and spices. This study aimed to investigate if dietary restriction (pseudoallergen-free and low histamine diet) can improve the clinical outcome in paediatric CSU patients.
Materials and methods: The present open-label randomized control trial was conducted in a paediatric tertiary care centre of Eastern India from September 2021 to August 2022. Paediatric CSU patients (n=140) attending the centre were randomly allocated to one of two treatment interventions: DR group (n=70, drug) or DRDI group (n=70, drugs and dietary intervention). Both groups were compared at baseline. The weekly urticaria activity score (UAS7) was calculated by trained parents. All data were entered in an Excel spreadsheet. T-test was used to compare the UAS7 of both groups at baseline, three and six weeks of treatment.
Results: There was no significant difference in demographic characteristics, clinical features, laboratory parameters and weekly urticaria activity score (UAS7) between groups at baseline. After six weeks of treatment, the UAS7 of patients in the DRDI group was lower as compared to those in the DR group (8.80±4.27 vs 10.19±4.66), though statistically insignificant (t=1.79, p=0.07).
Conclusion: Pseudoallergen-free diet is a safe and cost-effective measure to decrease CSU patients' symptoms.
目的:慢性自发性荨麻疹(CSU)是一种皮肤疾病,其特征为痒疹、血管性水肿或两者兼而有之,持续6周以上。食物中的“假过敏原”会引起与真正的过敏反应相似的超敏反应,并与CSU有关。这些物质包括食品添加剂、血管活性胺(组胺)和水果、蔬菜和香料中的一些天然物质。本研究旨在探讨饮食限制(无假过敏原和低组胺饮食)是否可以改善儿科CSU患者的临床预后。材料和方法:本开放标签随机对照试验于2021年9月至2022年8月在印度东部的一家儿科三级保健中心进行。参加该中心的儿科CSU患者(n=140)被随机分配到两种治疗干预措施中的一种:DR组(n=70,药物)或DRDI组(n=70,药物和饮食干预)。两组在基线进行比较。每周荨麻疹活动评分(UAS7)由受过训练的家长计算。所有数据都输入到Excel电子表格中。采用t检验比较两组在基线、治疗3周和6周时的UAS7。结果:两组患者的人口学特征、临床特征、实验室参数和每周荨麻疹活动度评分(UAS7)在基线时无显著差异。治疗6周后,DRDI组患者的UAS7低于DR组(8.80±4.27 vs 10.19±4.66),但差异无统计学意义(t=1.79, p=0.07)。结论:无假过敏原饮食是减轻CSU患者症状的一种安全、经济的措施。